Literature DB >> 14521577

Pfs230: from malaria transmission-blocking vaccine candidate toward function.

Kim C Williamson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14521577     DOI: 10.1046/j.1365-3024.2003.00643.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


× No keyword cloud information.
  36 in total

1.  Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230.

Authors:  Nicholas J MacDonald; Vu Nguyen; Richard Shimp; Karine Reiter; Raul Herrera; Martin Burkhardt; Olga Muratova; Krishan Kumar; Joan Aebig; Kelly Rausch; Lynn Lambert; Nikiah Dawson; Jetsumon Sattabongkot; Xavier Ambroggio; Patrick E Duffy; Yimin Wu; David L Narum
Journal:  J Biol Chem       Date:  2016-07-18       Impact factor: 5.157

Review 2.  Transmission-Blocking Vaccines: Old Friends and New Prospects.

Authors:  Festus K Acquah; Joshua Adjah; Kim C Williamson; Linda E Amoah
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

Review 3.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 4.  The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle.

Authors:  Silvia A Arredondo; Stefan H I Kappe
Journal:  Int J Parasitol       Date:  2016-11-27       Impact factor: 3.981

Review 5.  'Popping the clutch': novel mechanisms regulating sexual development in Cryptococcus neoformans.

Authors:  Yoon-Dong Park; Peter R Williamson
Journal:  Mycopathologia       Date:  2011-09-13       Impact factor: 2.574

6.  N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity.

Authors:  Mayumi Tachibana; Yimin Wu; Hideyuki Iriko; Olga Muratova; Nicholas J MacDonald; Jetsumon Sattabongkot; Satoru Takeo; Hitoshi Otsuki; Motomi Torii; Takafumi Tsuboi
Journal:  Clin Vaccine Immunol       Date:  2011-06-29

7.  Genome-level determination of Plasmodium falciparum blood-stage targets of malarial clinical immunity in the Peruvian Amazon.

Authors:  Katherine J Torres; Carlos E Castrillon; Eli L Moss; Mayuko Saito; Roy Tenorio; Douglas M Molina; Huw Davies; Daniel E Neafsey; Philip Felgner; Joseph M Vinetz; Dionicia Gamboa
Journal:  J Infect Dis       Date:  2014-11-07       Impact factor: 5.226

8.  Carboxypeptidases B of Anopheles gambiae as targets for a Plasmodium falciparum transmission-blocking vaccine.

Authors:  C Lavazec; C Boudin; R Lacroix; S Bonnet; A Diop; S Thiberge; B Boisson; R Tahar; C Bourgouin
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

Review 9.  Plasmodium falciparum gametocyte transit through the cutaneous microvasculature: A new target for malaria transmission blocking vaccines?

Authors:  Christian P Nixon
Journal:  Hum Vaccin Immunother       Date:  2016-05-16       Impact factor: 3.452

10.  Analysis of von Willebrand factor A domain-related protein (WARP) polymorphism in temperate and tropical Plasmodium vivax field isolates.

Authors:  Saber Gholizadeh; Navid Dinparast Djadid; Hamid Reza Basseri; Sedigheh Zakeri; Hossein Ladoni
Journal:  Malar J       Date:  2009-06-23       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.